Contrast-enhanced ultrasound of focal liver masses

Abstract

Non-invasive imaging is the current method of choice for the characterization of frequently discovered focal liver disease. Although historically, contrast-enhanced computed tomography (CT) and magnetic resonance (MR) scans have been selected for this purpose, contrast-enhanced ultrasound (CEUS) now offers a less expensive and safer method to acquire the same information. Performed with the intravenous injection of a microbubble contrast agent, CEUS provides some unique advantages that make it a valuable addition to an imaging toolbox. CEUS is performed in dynamic real-time, providing superior temporal resolution compared to other modalities and allowing detection of enhancement regardless of its timing or duration. CEUS is performed with a purely intravascular contrast agent, providing accurate depiction of the presence of microbubbles in the circulation in all phases of imaging. This compares with CT and MR contrast agents, which have a well-recognized interstitial phase. Resulting discordant imaging may occur especially in the portal venous phase, when CT and MR may show pseudoenhancement from interstitial contrast, while CEUS will accurately show washout in malignant tumors. Lastly, the contrast specific software used to perform CEUS has an excellent subtraction technique, which produces a contrast only image with high sensitivity to enhancement in thin septations and small nodules. CEUS makes a positive contribution to liver mass characterization in any situation.

Keywords

Contrast-enhanced ultrasound / liver / cancer / diagnosis

References

[1] Romanini L,Aiani L,Raieli G.Economic assessment of contrast-enhanced ultrasonography for evaluation of focal liver lesions: a multicentre Italian experience..Eur Radiol.2007;17 Suppl 6:F99-106

[2] Claudon M,Choi BI,Kudo M.Guidelines and good clinical practice recommendations for contrast enhanced ultrasound (CEUS) in the liver--update 2012: a WFUMB-EFSUMB initiative in cooperation with representatives of AFSUMB, AIUM, ASUM, FLAUS and ICUS..Ultraschall Med2013;34:11-29

[3] Claudon M,Choi BI,Kudo M.Guidelines and good clinical practice recommendations for Contrast Enhanced Ultrasound (CEUS) in the liver - update 2012: a WFUMB-EFSUMB initiative in cooperation with representatives of AFSUMB, AIUM, ASUM, FLAUS and ICUS..Ultrasound Med Biol2013;39:187-210

[4] Piscaglia F,Dietrich CF,Gilja OH.The EFSUMB Guidelines and Recommendations on the Clinical Practice of Contrast Enhanced Ultrasound (CEUS): update 2011 on non-hepatic applications..Ultraschall Med2012;33:33-59

[5] Piscaglia F.The safety of Sonovue in abdominal applications: retrospective analysis of 23188 investigations..Ultrasound Med Biol2006;32:1369-75

[6] Darge K,Ntoulia A,Coley BD.Safety of contrast-enhanced ultrasound in children for non-cardiac applications: a review by the Society for Pediatric Radiology (SPR) and the International Contrast Ultrasound Society (ICUS)..Pediatr Radiol2013;43:1063-73

[7] Schwarze V,Negrão de Figueiredo G,Clevert DA.Single-center study: evaluating the diagnostic performance and safety of contrast-enhanced ultrasound (CEUS) in pregnant women to assess hepatic lesions..Ultraschall Med2020;41:29-35

[8] Averkiou M. Nonlinear pulsing schemes for the detection of ultrasound contrast agents. Available from: https://www.academia.edu/25447720/Nonlinear_pulsing_schemes_for_the_detection_of_ultrasound_contrast_agents. [Last accessed on 13 Aug 2020]

[9] Burns PN,Simpson DH.Pulse inversion imaging of liver blood flow: improved method for characterizing focal masses with microbubble contrast..Invest Radiol2000;35:58-71

[10] Burns PN.Focal liver masses: enhancement patterns on contrast-enhanced images--concordance of US scans with CT scans and MR images..Radiology2007;242:162-74

[11] Wilson SR,Jang HJ.Enhancement patterns of focal liver masses: discordance between contrast-enhanced sonography and contrast-enhanced CT and MRI..AJR Am J Roentgenol2007;189:W7-12

[12] Wilson SR.An algorithm for the diagnosis of focal liver masses using microbubble contrast-enhanced pulse-inversion sonography..AJR Am J Roentgenol2006;186:1401-12

[13] Lyshchik A,Dietrich CF,Kim TK.Contrast-enhanced ultrasound of the liver: technical and lexicon recommendations from the ACR CEUS LI-RADS working group..Abdom Radiol (NY)2018;43:861-79 PMCID:PMC5886815

[14] Burns PN.Microbubble contrast for radiological imaging: 1. Principles..Ultrasound Q2006;22:15-8

[15] Strobel D,Blank W,Dietrich C.Contrast-enhanced ultrasound for the characterization of focal liver lesions--diagnostic accuracy in clinical practice (DEGUM multicenter trial)..Ultraschall Med2008;29:499-505

[16] Friedrich-Rust M,Nierhoff J,Vermehren J.Contrast-Enhanced Ultrasound for the differentiation of benign and malignant focal liver lesions: a meta-analysis..Liver Int2013;33:739-55

[17] Bhayana D,Jang HJ,Wilson SR.Hypervascular liver masses on contrast-enhanced ultrasound: the importance of washout..AJR Am J Roentgenol2010;194:977-83

[18] Sporea I,Bota S,Popescu A.Characterization of focal liver lesions using contrast enhanced ultrasound as a first line method: a large monocentric experience..J Gastrointest Liver Dis2014;23:57-63

[19] Kong WT,Huang BJ,Mao F.Value of wash-in and wash-out time in the diagnosis between hepatocellular carcinoma and other hepatic nodules with similar vascular pattern on contrast-enhanced ultrasound..J Gastroenterol Hepatol2014;29:576-80

[20] Murphy-Lavallee J,Kim TK,Wilson SR.Are metastases really hypovascular in the arterial phase? The perspective based on contrast-enhanced ultrasonography..J Ultrasound Med2007;26:1545-56

[21] Albrecht T,Burns PN,Harvey CJ.Improved detection of hepatic metastases with pulse-inversion US during the liver-specific phase of SHU 508A: multicenter study..Radiology2003;227:361-70

[22] Weskott HP.Detection and characterization of liver metastases..Radiologe2011;51:469-74

[23] Laumonier H,Balabaud C,Zucman-Rossi J.Role of contrast-enhanced sonography in differentiation of subtypes of hepatocellular adenoma: correlation with MRI findings..AJR Am J Roentgenol2012;199:341-8

[24] Kim TK,Burns PN,Wilson SR.Focal nodular hyperplasia and hepatic adenoma: differentiation with low-mechanical-index contrast-enhanced sonography..AJR Am J Roentgenol2008;190:58-66

[25] Dietrich CF,Braden B,Ott M.Contrast-enhanced ultrasound of histologically proven liver hemangiomas..Hepatology2007;45:1139-45

[26] Durot I,Willmann JK.Contrast-enhanced ultrasound of malignant liver lesions..Abdom Radiol (NY)2018;43:819-47

[27] Lee HS,An C.How to utilize LR-M features of the LI-RADS to improve the diagnosis of combined hepatocellular-cholangiocarcinoma on gadoxetate-enhanced MRI?.Eur Radiol2019;29:2408-16

[28] Fowler KJ,Hope TA,Wilson SR.LI-RADS M (LR-M): definite or probable malignancy, not specific for hepatocellular carcinoma..Abdom Radiol (NY)2018;43:149-57

[29] Trillaud H,Valette PJ,Schmutz G.Characterization of focal liver lesions with SonoVue-enhanced sonography: international multicenter-study in comparison to CT and MRI..World J Gastroenterol2009;15:3748-56 PMCID:PMC2726452

[30] Seitz K,Strobel D,Friedrich-Rust M.Contrast-enhanced ultrasound (CEUS) for the characterization of focal liver lesions in clinical practice (DEGUM Multicenter Trial): CEUS vs. MRI--a prospective comparison in 269 patients..Ultraschall Med2010;31:492-9

[31] Guang Y,Ding H,Huang Y.Diagnosis value of focal liver lesions with SonoVue®-enhanced ultrasound compared with contrast-enhanced computed tomography and contrast-enhanced MRI: a meta-analysis..J Cancer Res Clin Oncol2011;137:1595-605